A	O
total	O
of	O
21	O
mild	O
patients	O
with	O
COVID	O
-	O
19	O
were	O
enrolled	O
in	O
this	O
pilot	O
RCT	O
from	O
February	O
2020	O
through	O
March	O
2020	O
(	O
Trial	O
Registration	O
:	O
ChiCTR2000029431	O
)	O
.	O

Patients	O
were	O
considered	O
eligible	O
in	O
this	O
study	O
on	O
the	O
basis	O
of	O
the	O
WHO	O
interim	O
guidance3	O
and	O
they	O
were	O
laboratory	O
-	O
confirmed	O
positive	O
on	O
by	O
the	O
means	O
of	O
real	O
-	O
time	O
reverse	O
-	O
transcriptase	O
â€“	O
polymerase	O
-	O
chain	O
-	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
of	O
nasal	O
and	O
pharyngeal	O
swab	O
specimens	O
.	O

Randomization	O
was	O
performed	O
and	O
ensured	O
with	O
the	O
use	O
of	O
Web	O
-	O
based	O
randomization	O
system	O
.	O

Patients	O
were	O
assigned	O
,	O
in	O
a	O
1	O
:	O
1	O
ratio	O
,	O
into	O
control	O
(	O
11	O
patients	O
)	O
and	O
99mTc	O
-	O
MDP	O
group	O
(	O
10	O
patients	O
)	O
.	O

Patients	O
in	O
the	O
control	O
group	O
received	O
routine	O
treatment	O
according	O
to	O
Diagnostic	O
of	O
COVID	O
-	O
19	O
criteria	O
issued	O
by	O
National	O
Health	O
Commission	O
of	O
China	O
.	O

Patients	O
assigned	O
to	O
the	O
99mTc	O
-	O
MDP	O
group	O
received	O
a	O
combination	O
of	O
routine	O
treatment	O
and	O
an	O
administration	O
of	O
99mTc	O
-	O
MDP	O
injection	O
of	O
5ml	O
/	O
day	O
.	O

Both	O
of	O
the	O
patients	O
in	O
the	O
control	O
and	O
99mTc	O
-	O
MDP	O
groups	O
were	O
treated	O
for	O
7	O
days	O
.	O

The	O
primary	O
end	O
point	O
was	O
the	O
CT	B-PrimaryOutcome
-	I-PrimaryOutcome
based	I-PrimaryOutcome
radiological	I-PrimaryOutcome
pulmonary	I-PrimaryOutcome
changes	I-PrimaryOutcome
from	B-TimeFrame
baseline	I-TimeFrame
to	I-TimeFrame
7	I-TimeFrame
days	I-TimeFrame
.	O

The	O
secondary	O
end	O
points	O
were	O
disease	B-SecondaryOutcome
progression	I-SecondaryOutcome
from	I-SecondaryOutcome
mild	I-SecondaryOutcome
to	I-SecondaryOutcome
severe	I-SecondaryOutcome
on	B-TimeFrame
the	I-TimeFrame
day	I-TimeFrame
7	I-TimeFrame
,	O
as	O
well	O
as	O
radiological	B-SecondaryOutcome
pulmonary	I-SecondaryOutcome
changes	I-SecondaryOutcome
during	B-TimeFrame
7	I-TimeFrame
days	I-TimeFrame
to	I-TimeFrame
14	I-TimeFrame
days	I-TimeFrame
after	I-TimeFrame
treatment	I-TimeFrame
.	O

